ArticleCureus2026
Multimodal Management of Facial Acne Scarring Using Energy-Based Devices and Injectable Therapies: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Comparative efficacy and safety of fractional carbon dioxide and erbium-based fractional lasers for atrophic acne scars: A systematic review and meta-analysis.Lasers in medical science · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acne vulgaris is a highly prevalent chronic inflammatory disorder that frequently results in permanent scarring, with atrophic scars representing the predominant type. The management of atrophic acne scarring is challenging due to variability in scar morphology, depth of dermal involvement, and patient-specific factors, often necessitating individualized and multimodal treatment strategies. We report the case of a 35-year-old male with facial atrophic acne scars treated using a combination of picosecond laser therapy, erbium:YAG laser resurfacing, injectable poly-L-lactic acid, hyaluronic acid filler, and microneedling radiofrequency over a structured treatment course. The patient demonstrated progressive improvement in scar appearance and skin texture, with good tolerability and no reported adverse events throughout follow-up. This case highlights the clinical application of a multimodal approach that integrates energy-based devices and injectable therapies to address multiple structural components of atrophic acne scarring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.